CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
nicotine transdermal system +3 moredrug
Likely dose
nicotine transdermal system 21 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00390559
NCT00390559N/ACompleted

Effects of Transdermal Nicotine on Tobacco Withdrawal and the Effects of Smoking-related Stimuli in Men and Women

Virginia Commonwealth University·interventional·Posted Oct 20, 2006·Updated Jul 18, 2012

In Brief

A clinical study evaluating nicotine transdermal system, Nicotine transdermal system, and 2 other interventions for Drug Addiction and Smoking Cessation. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Treatment studies have demonstrated that current smoking cessation techniques are less effective for women. The purpose of this study is to determine the role that gender plays in the effectiveness of nicotine replacement therapy. In addition, the purpose of this study is to determine whether men and women differ in their response to smoking-related stimuli (e.g., taste or smell of a lit cigarette). Conclusions drawn from this study may help to improve cessation interventions for all smokers, particularly women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 20, 2006
Enrollment StartOct 1, 2005
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 19.7 years ago

Interventions

nicotine transdermal systemdrug

21 mg nicotine transdermal system

Nicotine transdermal systemdrug

Placebo nicotine patch

Nicotine containing cigaretteother

Nicotine containing cigarette

Placebo cigaretteother

Non nicotine containing cigarette